For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Active tDCS and Fluency Training | Participants will receive anodal tDCS at 2milliampere (mA) intensity for 20 minutes during speech fluency training (5 consecutive days). Anodal tDCS: 20 minutes of 2mA anodal stimulation. Fluency training: Speaking along with a metronome and/or speaking along with another person (choral speech) for 20 minutes | 0 | None | 0 | 12 | 12 | 12 | View |
| Sham tDCS and Fluency Training | Participants will receive sham tDCS. Sham stimulation will involve 30 seconds of stimulation at the beginning of the 20 minutes of speech fluency training (5 consecutive days). Fluency training: Speaking along with a metronome and/or speaking along with another person (choral speech) for 20 minutes Sham tDCS: For sham stimulation, current is ramped up and back down over 30 seconds. | 0 | None | 0 | 11 | 10 | 11 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Headache | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Neck pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Scalp pain | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Tingling | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Warm sensation | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Sleepiness | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Trouble concentrating | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Acute mood change | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Nervousness | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Changes in visual sensations | SYSTEMATIC_ASSESSMENT | General disorders | None | View |